About Us

Guangdong Victory Biotech Co., Ltd.

With 15 years of in-depth dedication to the collagen industry, we are a technology-driven enterprise integrating the R&D of high-purity raw materials and the manufacturing of medical device semi-finished products. Our manufacturing facility is situated in China’s key advanced industrial cluster, equipped with a 3,000 ㎡ controlled clean workshop that meets strict medical device quality standards. Leveraging the advantages of a vertically integrated supply chain, we implement standardized operations and traceable management throughout the entire process from raw material extraction to finished product output, ensuring all products meet clinical-grade standards in safety, stability and efficacy.
1. Medical-grade Raw Material Supply
We provide high-end raw materials with stable physicochemical properties and controlled endotoxin levels to meet the R&D and mass production needs of medical devices:

• Type I Collagen Raw Material: We offer comprehensive compliance solutions to support downstream clients in medical device licensing and application procedures.
• Multi-form Adaptation: Available in high-purity powder, highly concentrated slurry and solution, with outstanding bioactivity and excellent redissolvability.

2. Clinical End-product System
Supported by mature cross-linking technology and forming processes, we deliver multi-field application solutions as well as OEM/ODM services:

• Guided Tissue Regeneration Membrane (GTR/GBR)
• Collagen Sponge Dressing
• Artificial Bone Repair Material
• Collagen Implant (Subcutaneous Filler)

3. Custom R&D & Compliance Empowerment
Victory Biotech commits to delivering all-round integrated technical support to accelerate the clinical transformation of partners’ products:

• Performance Customization: Targeted R&D on mechanical properties, degradation rate, pore structure and product forms based on clinical demands.
• Compliance Acceleration: Supported by a sound quality management system and Master File registration, we effectively shorten the registration cycle of downstream medical devices.
• Production & R&D Transformation: Supported by a 3,000 ㎡ standardized production base, we realize seamless transition from laboratory prototypes to industrial mass production.

World Marketing